◆ 会议时间：2024年12月6-8日
◆ 会议地点：新加坡/Singapore - Suntec Singapore Convention & Exhibition Centre
◆ 会议简介：
2024年欧洲肿瘤内科学会(ESMO)亚洲年会（大会）将于2024年12月6-8日在新加坡举行，会议由欧洲肿瘤内科学会(ESMO)主办。ESMO亚洲年会（ESMO ASIA CONGRESS 2024）将汇聚最具经验的国际专家，提供高水准的涵盖所有主要肿瘤类型的肿瘤学教育方案，并为国际同行提供重要的交流机会，使亚太地区的肿瘤学专业人士能够与快速发展的肿瘤学科学与教育保持同步。ESMO亚洲大会是全球和亚洲临床医生战略合作的结果，将由来自世界各地的顶级肿瘤学专家提供的一流的科学和教育项目，大会是亚太地区讨论肿瘤学领域的最新数据和最新突破成果的领先平台，并重点关注区域特性。
欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织，ESMO一直以宣推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
2024 ESMO Asia Congress - European Society for Medical Oncology Asia Congres
Date: 6-8 December 2024
Venue: Suntec Singapore Convention & Exhibition Centre, Singapore, Republic of Singapore
ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region.
It provides a platform for participants to share and discuss the latest research findings, clinical trials, and treatment strategies in the field.
The event brings together oncologists, researchers, healthcare professionals, and industry representatives from Asia and around the world.
ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer.
Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.
We look forward to welcoming you to ESMO Asia 2024, for plenty of opportunities to expand your knowledge, and advance your career!
摘要征文投稿：
Abstract submission deadlines
Abstracts
Trial in Progress
Intent to submit LBA |
Tuesday, 16 July 2024
18:00 SGT (Local Singapore Time)
12:00 CEST (Central European Summer Time)
|
Late-breaking abstracts (LBA) |
Tuesday, 8 October 2024
18:00 SGT (Local Singapore Time)
12:00 CEST (Central European Summer Time)
A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline of 16 July 2024 |
点此提交摘要>>>Submit Abstract>>>
Outcome notifications
Outcome notifications are expected to be made available to first authors and submitters by mid-September 2024.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by mid-October 2024.
Information for presenters
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid-September 2024, in the section “Information for Presenters”.
Abstract submission categories
Breast cancer, early stage |
Head and neck cancer, excluding thyroid |
Breast cancer, locally advanced |
Palliative care |
Breast cancer, metastatic |
Precision medicine |
Developmental therapeutics |
Supportive care |
Gastrointestinal tumours, colorectal |
Thoracic tumours, early stage |
Gastrointestinal tumours, non-colorectal |
Thoracic tumours, locally advanced |
Genitourinary tumours, prostate |
Thoracic tumours, metastatic |
Genitourinary tumours, non-prostate |
Miscellaneous |
Gynaecological cancers |
|
Late-breaking abstracts (LBA)
Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.
The final late-breaking abstract deadline of 8 October 2024 is under no circumstances to be considered as an extension of the general submission deadline (16 July 2024).
Trial in progress abstracts (TiP)
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Asia Congress 2024.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Young Oncologist (YO) Patient case studies
Challenging clinical case studies in the new era of personalised medicine may be submitted by young oncologists under 40 years of age.
Presentation and publication of accepted abstracts
The ESMO Asia 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Presidential Symposium – Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
All accepted abstracts, including late-breaking abstracts, will be published online only in the ESMO Asia Congress 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.
Publication schedule of accepted abstracts
Details regarding the publication of accepted abstracts will be available here.
ESMO Merit Travel Grants
A limited number of Merit Travel Grants to the ESMO Asia Congress 2024 are available, upon application, to first authors who submit abstracts considered deserving of recognition. Candidates must be ESMO members under the age of 40 (forty). Selection will be made by the ESMO Asia Congress 2024 Scientific Committee on a competitive basis from among the accepted abstracts.
注册费：
Registration fees and deadlines
Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in SGD by the given deadlines.
ESMO membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied Please visit the membership page to check eligibility criteria, benefits, and to complete the membership application.
Registration fees for onsite only
(Net amounts, SGD) |
Early registration fee
until 4 September 2024 |
Late registration fee
until 6 November 2024 |
Full registration fee
from 7 November 2024 |
ESMO Member |
SGD 425.00 |
SGD 620.00 |
SGD 930.00 |
ESMO Member Developing Countries* |
SGD 172.00 |
SGD 258.00 |
SGD 287.00 |
ESMO Member in Training** |
SGD 121.00 |
SGD 155.00 |
SGD 207.00 |
ESMO Member Undergraduate Student |
SGD 121.00 |
SGD 155.00 |
SGD 207.00 |
ESMO Member Nurse |
SGD 121.00 |
SGD 155.00 |
SGD 207.00 |
ESMO Member Patient Advocate |
SGD 121.00 |
SGD 155.00 |
SGD 207.00 |
Non-Member |
SGD 654.00 |
SGD 955.00 |
SGD 1,448.00 |
* Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO Members must be under 40 and in training to qualify for this fee
In-person participation includes:
- Participation in the scientific and educational live sessions with the possibility to interact with the expert panel table
- Onsite networking opportunity with faculty and peers
- Entry to the Poster area
- Interaction with the industry partners in the trade exhibition
- Participation in the Industry Satellite Symposia
- Post-event resources
Other registration fees for onsite only
(Net amounts, SGD) |
Fee |
Access |
Exhibitor visitor badge |
SGD 182.00 |
- Exhibition area
- Industry satellite area
- Private meeting area
Access to sessions and webcast not included |
Private meeting badge |
Industry satellite badge |
Third Party Media |
SGD 400.00 |
- Venue common areas
- Filming area
- Exhibition area and Private meeting rooms upon invitation only
Access to sessions and webcast not included |
Confirmation
By mid of November 2024, delegates will receive the registration confirmation email with access for the ESMO Asia Congress 2024.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
